Journal Browser

Go Edit a Special Issue

Archive

Special Issue Title:

Pathophysiology of Sepsis

Deadline for manuscript submissions: 31 August 2021

Print Special Issue Flyer (3)

Special Issue Editor

  • Guest Editor

    Dr. Susan F. FitzpatrickE-MailWebsite

    Scientific Researcher at University College Dublin, Belfield, Dublin 4, Ireland

    Interests: Hypoxia and inflammation, Inflammatory bowel disease, Sepsis, Innate immune, Clinical symptomology

Special Issue Information

Sepsis defined as a dysregulated host response to infection leading to organ failure is a global health crisis. Worldwide approximately 49 million incidents of sepsis and 11 million deaths related to sepsis were reported in 2017. Sepsis is not disappearing; in fact, the number of patients with sepsis is increasing worldwide, due to the development of antibiotic resistant bacteria, emergence of novel infectious diseases e.g. COVID-19 and increased longevity these numbers are dramatically increasing each year. Thus, a coordinated global effort is urgently needed to tackle this crisis.


The pathophysiology of sepsis is complex. Previously, it was believed that sepsis was simply an exaggerated, hyperinflammatory response with patients dying from inflammation-induced organ injury. However, data over the last two decades has shown that the manifestation of sepsis can no longer be attributed only to the infectious agent and the immune response it engenders, but is also due to dysregulated coagulation, cellular dysfunction, immunosuppression, altered metabolism and organ dysfunction. Despite these advances in our understanding we still lack a full understanding of the pathogenesis of sepsis, and many questions remain. For instance, what is the mechanism for the initiation, maintenance, and termination of sepsis? What is the underlying mechanism of sepsis causing cellular and subcellular dysfunction? How does cellular dysfunction cause organ failure? What are the mechanisms contributing to dysregulated coagulation and metabolism? Are septic patients hyperinflammatory or immunocompromised?


In this special issue we aim to bring together Original Research, Reviews, Mini-Reviews, Perspective, Protocols, Case Report articles to enhance our knowledge of the pathophysiology of sepsis. In doing so we hope to identify new avenues for healthcare intervention and to accelerate improved diagnosis and treatment for sepsis. 

Keywords

Sepsis, Hyperinflammatory response, Dysregulated coagulation, Cellular dysfunction, Immunosuppression, Metabolism, Organ dysfunction, Immunocompromise

Manuscript Submission Information

Manuscripts should be submitted online by submit system. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Original articles, case reports or comprehensive reviews are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Signa Viate is an international peer-reviewed open access semi-annual journal published by MRE Press. Please visit the Instructions for Authors page before submitting a manuscript.The Article Processing Charge (APC) for publication in this open access journal is $1200. We normally offer a discount greater than 30% to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and use good English.

Share This Special Issue

Published Papers (0 papers)

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) The Science Citation Index (SCI) is a citation index originally produced by the Institute for Scientific Information (ISI) and created by Eugene Garfield. It (Science Citation Index Expanded) covers more than 8,500 notable and significant journals, across 150 disciplines in science and technology, from 1900 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

IndexCopernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time

Conferences